Navigation Links
Society for Clinical Research Sites Receives Unprecedented Response from Industry Stakeholders to Support Sites by Joining Corporate Partnership Program
Date:6/20/2013

ROCKVILLE, Md., June 20, 2013 /PRNewswire/ -- The Society for Clinical Research Sites (SCRS) is proud to announce the launch of the Global Impact Partnership (GIP) Program.  In just over a month, twelve organizations have joined SCRS' commitment to research site's success.  SCRS Global Impact Partners will provide ongoing development, feedback, and support of industry initiatives designed to include and improve the voice of clinical research sites.  In just seven months since its announcement, SCRS has grown its global membership to represent 1,300 sites in 12 countries.  Within a constantly evolving industry, the Global Impact Partnership Board will work in tandem with SCRS' Leadership Council to identify the work streams most significant to the success of research sites across the world.  Each GIP member will appoint one executive level team member to represent their organization and each organization has made a two year commitment to SCRS. 

The founding GIP industry partners include:
Amgen, AstraZeneca, Eli Lilly, PPD, and Roche

While GIP professional partners include:
Acurian, Aspire IRB, Bio-Optronics, Inc., CFS Clinical, Clinical Site Services, DAC Patient Recruitment Services, and ePharmaSolutions.

More industry GIP members will be announced in the months ahead as are invited.  However, the supplier seats are limited to only 12 organizations.  The first meeting of the GIP Board will be held at this year's Site Solutions Summit in Amelia Island, FL.  The GIP Board will work towards industry changes from operational management, to contracts, to subject retention, and more.  Their collaboration will SCRS continue throughout the year.

SCRS President, Christine Pierre states that "The response we have received from sites joining at such a rapid rate was not a surprise; sites are committed to the industry and to our volunteers.  However, the response our community of sites has received from industry has affirmed that the mission of SCRS to represent the global site community and ensure our voice is heard was long overdue, and they want to be a part of the advancement of SCRS.  It has long been my position that success in the clinical research ecosystem is dependent on the foundation of a strong site base.  Without sites there are no subjects, without subjects there are no new treatments.  Critical success factors are different around the globe, and we look forward to working with our GIPs, Leadership Council and SCRS members to ensure all sites succeed."

About SCRS
SCRS is a trade organization representing global clinical research sites representing 1,300 sites in 12 countries in just seven months of its launch. SCRS' mission is to unify and amplify the voice of the global clinical research site community. SCRS has become an active partner in industry-wide dialogues focused on improving the clinical research enterprise among the many industry initiatives. Sites, as well as companies that sponsor or support the work conducted at the clinical research sites, will also benefit from membership. Visit www.myscrs.org.


'/>"/>
SOURCE Society for Clinical Research Sites
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Celebrating 25 Years and Counting: Leukemia and Lymphoma Societys "Team In Training" Goes the Distance and Beyond for Blood Cancer Patients
2. "Miracle" Breast Cancer Drug and "Youth Hormone" Pill Steal Show at Prestigious Endocrine Society Conference
3. Prime Therapeutics receives prestigious Silver Anvil Award from Public Relations Society of America
4. The Leukemia & Lymphoma Society and Dana-Farber Cancer Institute to Bring Clinical Trials to Local Communities
5. The Leukemia & Lymphoma Society Applauds FDAs Approval of Lenalidomide for Patients with Relapsed or Refractory Mantle Cell Lymphoma
6. Nektar Presents Positive Preclinical Data for NKTR-214, a Novel Cancer Immunotherapy, At the 2013 American Society of Clinical Oncology Annual Meeting
7. Oramed Selected to Present at the 81st European Atherosclerosis Society Congress in Lyon, France, June 2-5, 2013
8. Nektar Presents Target-Specific Biomarkers Being Assessed in Ongoing Phase 3 BEACON Study of Etirinotecan Pegol for the Treatment of Metastatic Breast Cancer at the 2013 American Society of Clinical Oncology Annual Meeting
9. Genomic Health Announces Results of Ten Studies in Breast, Prostate and Colon Cancers at the American Society of Clinical Oncology (ASCO) Annual Meeting
10. ViewRays Chief Medical Officer Honored by American Society for Radiation Oncology (ASTRO)
11. Amgen To Webcast Investor Meeting At Upcoming American Society Of Clinical Oncology Annual Meeting
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... -- Research and Markets has announced the addition ... to their offering. The ... commercial environment for MedImmune to enter. The US ageing population ... to drive considerable growth for effective anti-influenza medications. The introduction ... considerably, but development is still in its infancy. ...
(Date:6/23/2016)... and INDIANAPOLIS , June 23, ... a Lilly Diabetes Tomorrow,s Leaders Scholarship is any indication, ... winners, announced today online at www.diabetesscholars.org by ... 1 diabetes stand in the way of academic and ... the Foundation,s scholarship program since 2012, and continues to ...
(Date:6/23/2016)... PRINCETON, N.J. , June 23, 2016  Guerbet ... of Premier Inc.,s Supplier Horizon Award . ... this year, Guerbet was recognized for its support of ... value creation through clinical excellence, and commitment to lower ... delighted to receive this recognition of our outstanding customer ...
Breaking Medicine Technology:
(Date:6/26/2016)... ... June 26, 2016 , ... Pixel Film Studios Released ProSlice Levels, a ... can give their videos a whole new perspective by using the title layers ... Film Studios. , ProSlice Levels contains over 30 Different presets to choose from. ...
(Date:6/25/2016)... TX (PRWEB) , ... June 25, 2016 , ... Austin ... of the American College of Mohs Surgery and to Dr. Russell Peckham for medical ... and highly effective treatment for skin cancer. The selective fellowship in Mohs Micrographic Surgery ...
(Date:6/25/2016)... ... June 25, 2016 , ... ... recover from injury. Recently, he has implemented orthobiologic procedures as a method for ... is one of the first doctors to perform the treatment. Orthobiologics are substances ...
(Date:6/24/2016)... ... 24, 2016 , ... June 19, 2016 is World Sickle Cell Observance Day. ... the benefits of holistic treatments, Serenity Recovery Center of Marne, Michigan, has ... , Sickle Cell Disease (SCD) is a disorder of the red blood cells, which ...
(Date:6/24/2016)... , ... June 24, 2016 , ... Comfort Keepers® of ... Cancer Society and the Road To Recovery® program to drive cancer patients to and ... other adults to ensure the highest quality of life and ongoing independence. Getting ...
Breaking Medicine News(10 mins):